ask="N/A"
ask_size="N/A"
average_daily_volume="837948"
bid="N/A"
bid_size="N/A"
book_value="-0.41"
change="-0.01"
change_from_200_day_moving_average="-0.17"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-0.97"
change_From_52_week_low="0.28"
change_in_percent="-1.35%"
close="0.54"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.08"
ebitda="-1.60M"
eps_estimate_current_year="-0.08"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.03"
ex_dividend_date="N/A"
float_shares="133560000"
high="0.57"
high_52_weeks="1.51"
last_trade_date="2/2/2017"
last_trade_price="0.54"
last_trade_size="3290"
last_trade_time="4:02pm"
low="0.51"
low_52_weeks="0.26"
market_capitalization="83.97M"
moving_average_200_day="0.71"
moving_average_50_day="0.61"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.25"
open="0.57"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.92%"
percent_change_from_50_day_moving_average="-12.04%"
percent_change_from_52_week_high="-64.24%"
percent_change_from_52_week_low="+107.53%"
previous_close="0.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.72"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="17.20"
stock_exchange="ASE"
symbol="NAVB"
volume="408109"
weeks_range_52="0.26 - 1.51"
